Announcement
02 Jun 2020
On 2 June 2020, U.S. BARDA and DARPA announced collaborating with AstraZeneca to advance the monoclonal antibodies combination therapy for the treatment and protection against COVID-19.
Source
Sign in to access
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
02 Jun 2020
Revocation date:
No revocation date
Updated: 02 Jun 2020
Financial grant
In force
On 2 June 2020, the Biomedical Advanced Research and Development Authority (BARDA) and the Defense Advanced Research Projects Agency (DARPA) within the Department of Defense announced collaborating wi...
Sign in to see more
Threads
See all
This state act is not part of any Thread yet.